Some traditional Chinese medications might be used as a complementary and alternative approach for primary and secondary prevention of cardiovascular disease, but further long-term study is needed.
13 Jun 2017
Practice-changing points may influence how internists prescribe aspirin for the primary prevention of heart disease.
1 Mar 2019
Patients who continued aspirin had a 4.1% yearly incidence of cardiovascular events, compared to 5.4% among those who stopped taking the drug, while the risk of discontinuation corresponded to one additional cardiovascular event for every 74 patients who stopped taking aspirin in a year.
3 Oct 2017
Marijuana use has risen, so internists need to understand its real risks as well as its potential clinical uses, such as for chronic pain, chemotherapy-induced nausea and vomiting, and multiple sclerosis spasticity symptoms.
1 Apr 2019
Experts considered evidence from the FOURIER trial and the SPIRE-1 and SPIRE-2 trials, as well as evidence on addition of ezetimibe to statin therapy after acute coronary syndrome.
12 Sep 2017
The new three-step tool aims to provide a framework for delivering appropriate risk-reducing strategies to Medicare patients with a 10-year atherosclerotic cardiovascular disease risk greater than 30%.
8 Nov 2016
Experts remain uncertain how to judge wearables and smartphone apps' cost-effectiveness, data quality, and clinical implications among pre-symptomatic patients diagnosed with atrial fibrillation.
1 Feb 2020
An accompanying editorial said the CHA2DS2-VASc cutoff should be considered a starting point for individualized assessment rather than a threshold that applies the same way to everyone.
25 Sep 2018
Antiretroviral therapy has made an impact in treating HIV, but preexposure prophylaxis has created a huge opportunity in preventing infection, with internists poised to play a role.
1 Mar 2020
Guidelines for reducing cardiovascular risk are shifting with the evidence.
1 Jun 2017